Dr Wendy Lipworth

NHMRC Career Development Fellow
Centre for Values, Ethics & Law in Medicine (VELIM), School of Public Health

Telephone +61 2 9036 3405
Fax +61 2 9036 3436

Curriculum vitae Curriculum vitae

Map

Biographical details

Career summary: I am a bioethicst and health social scientist, and Senior Research Fellow at the Centre for Values, Ethics and the Law in Medicine, University of Sydney. I completed my medical degree at the University of New South Wales in 1999, and moved into academia in 2002. I have since completed a MSc by research (Sydney University) on biobanking ethics; a PhD (Sydney University) on the ethics of journal peer review; and a Postdoctoral Fellowship at UNSW on pharmaceutical policy.

Research support: I have been supported by the National Health & Medical Research Council (NHMRC) throughout my academic career. My PhD was supported by a NHMRC Scholarship; my postdoctoral research was supported by a NHMRC Training Fellowship, and I am currently supported by a NHMRC Career Development Fellowship. In addition to these Fellowships (and numerous associated smaller travel grants), I have been a Chief Investigator on NHMRC and Australian Research Council (ARC) grants totalling over $3.5 million.

Contributions to the field: I have published over 90 peer reviewed journal articles and nine book chapters in ethics, social science, law and medical publications, and my research has been presented both nationally and internationally. I have worked with the Australian Bone Marrow Donor Registry, the Royal Australasian College of Physicians, Medicines Australia, the NSW Ministry of Health. In 2013, I became the inaugural Chair of a Special Interest Group on ethics for the Drug Information Association—a major, global, non-profit organisation with more than 18,000 members worldwide who are involved in the development and regulation of pharmaceuticals. I am Associate Editor for the Journal of Bioethical Inquiry and Therapeutic Innovation and Regulatory Science.

Supervision and mentoring: I lead a research team consisting of two postdoctoral researchers and two research assistants. I am primary supervisor or joint primary supervisor of three PhD students and co-supervise four other PhD students and one Masters Student. I have co-supervised to completion one PhD students and one Honours students. I have also mentored several medical, law and public health students through research projects.

Research interests

I am a medically trained bioethicist and health social scientist, and Senior Research Fellow at the Centre for Values, Ethics and the Law in Medicine, University of Sydney. My program of research focuses on the ethics and politics of biomedical innovation, with an emphasis on:
Pharmaceutical innovation and policymaking
Biobanks and big data research, and
Biomedical publication.
My research is based on the recognition that, while there have been many exciting advances in recent years, there are also significant methodological, ethico-legal, economic and organisational challenges to effective and responsible biomedical innovation.
The task of addressing these challenges usually falls to policymakers, which can be difficult because the issues at stake are complex and value-laden, and stakeholders often disagree as to what should be done.
My research aims to assist policymakers through a combination of 1) empirical research—exploring stakeholders' understandings of the challenges to effective and responsible innovation, and 2) theoretical analysis—drawing on ideas about how society should be organised so that innovation addresses the needs and values of the populations it is intended to benefit.
I am currently supported by a National Health & Medical Research Council Career Development Fellowship. I am lead Chief Investigator on two NHMRC Project Grants, focused on:
1. Managing access to high cost cancer medicines
2. Managing the conflicts of interest that can arise from interactions between biomedical researchers, policymakers, clinicians and the pharmaceutical industry.
I am also a Chief Investigator on NHMRC and Australian Research Council (ARC) grants on biobank/big data networks, autologous stem cell "therapy" and medicines safety advisories, and I supervise research into the ethics and politics of off-label prescribing, accelerated access to medicines, and the use of animal products in complementary medicines.
I am a medically trained bioethicist and health social scientist, and Senior Research Fellow at the Centre for Values, Ethics and the Law in Medicine, University of Sydney. My program of research focuses on the ethics and politics of biomedical innovation, with an emphasis on:
Pharmaceutical innovation and policymaking
Biobanks and big data research, and
Biomedical publication.
My research is based on the recognition that, while there have been many exciting advances in recent years, there are also significant methodological, ethico-legal, economic and organisational challenges to effective and responsible biomedical innovation.
The task of addressing these challenges usually falls to policymakers, which can be difficult because the issues at stake are complex and value-laden, and stakeholders often disagree as to what should be done.
My research aims to assist policymakers through a combination of 1) empirical research—exploring stakeholders' understandings of the challenges to effective and responsible innovation, and 2) theoretical analysis—drawing on ideas about how society should be organised so that innovation addresses the needs and values of the populations it is intended to benefit.
I am currently supported by a National Health & Medical Research Council Career Development Fellowship. I am lead Chief Investigator on two NHMRC Project Grants, focused on:
1. Managing access to high cost cancer medicines
2. Managing the conflicts of interest that can arise from interactions between biomedical researchers, policymakers, clinicians and the pharmaceutical industry.
I am also a Chief Investigator on NHMRC and Australian Research Council (ARC) grants on biobank/big data networks, autologous stem cell "therapy" and medicines safety advisories, and I supervise research into the ethics and politics of off-label prescribing, accelerated access to medicines, and the use of animal products in complementary medicines.
I am a medically trained bioethicist and health social scientist, and Senior Research Fellow at the Centre for Values, Ethics and the Law in Medicine, University of Sydney. My program of research focuses on the ethics and politics of biomedical innovation, with an emphasis on:
Pharmaceutical innovation and policymaking
Biobanks and big data research, and
Biomedical publication.
My research is based on the recognition that, while there have been many exciting advances in recent years, there are also significant methodological, ethico-legal, economic and organisational challenges to effective and responsible biomedical innovation.
The task of addressing these challenges usually falls to policymakers, which can be difficult because the issues at stake are complex and value-laden, and stakeholders often disagree as to what should be done.
My research aims to assist policymakers through a combination of 1) empirical research—exploring stakeholders' understandings of the challenges to effective and responsible innovation, and 2) theoretical analysis—drawing on ideas about how society should be organised so that innovation addresses the needs and values of the populations it is intended to benefit.
I am currently supported by a National Health & Medical Research Council Career Development Fellowship. I am lead Chief Investigator on two NHMRC Project Grants, focused on:
1. Managing access to high cost cancer medicines
2. Managing the conflicts of interest that can arise from interactions between biomedical researchers, policymakers, clinicians and the pharmaceutical industry.
I am also a Chief Investigator on NHMRC and Australian Research Council (ARC) grants on biobank/big data networks, autologous stem cell "therapy" and medicines safety advisories, and I supervise research into the ethics and politics of off-label prescribing, accelerated access to medicines, and the use of animal products in complementary medicines.I am a medically trained bioethicist and health social scientist, and Senior Research Fellow at the Centre for Values, Ethics and the Law in Medicine, University of Sydney. My program of research focuses on the ethics and politics of biomedical innovation, with an emphasis on:

My program of research focuses on the ethics and politics of biomedical innovation, with an emphasis on:

• Pharmaceutical innovation and policymaking

• Biobanks and big data research, and

• Biomedical publication.

My research is based on the recognition that, while there have been many exciting advances in recent years, there are also significant methodological, ethico-legal, economic and organisational challenges to effective and responsible biomedical innovation.

The task of addressing these challenges usually falls to policymakers, which can be difficult because the issues at stake are complex and value-laden, and stakeholders often disagree as to what should be done.

My research aims to assist policymakers through a combination of 1) empirical research—exploring stakeholders' understandings of the challenges to effective and responsible innovation, and 2) theoretical analysis—drawing on ideas about how society should be organised so that innovation addresses the needs and values of the populations it is intended to benefit.

Teaching and supervision

I run a 6 credit-point unit of study on "Medicines Policy, economics and ethics" (BETH5209) in the Sydney University Masters of Bioethics program.

Current research students

Project title Research student
Data Sharing, Consent and Altruism in Australian Genomics Research. Jonnie KENNEDY
The Ethics and Politics of Accelerated Access to Medicines, Including Coverage with Evidence Development Jessica PACE

Current projects

I am currently lead Chief Investigator on two NHMRC Project Grants, focused on:

1. Managing access to high cost cancer medicines

2. Managing the conflicts of interest that can arise from interactions between biomedical researchers, policymakers, clinicians and the pharmaceutical industry.

I am also a Chief Investigator on NHMRC and Australian Research Council (ARC) grants onbiobank/big data networks, autologous stem cell "therapy" and medicines safety advisories, and I supervise research into the ethics and politics of off-label prescribing, accelerated access to medicines, and the use of animal products in complementary medicines.

Associations

-AABHL(Australasian Association of Bioethics and Health Law)

-DIA (Drug Information Association)

-Group Relations Australia

International links

United States

(University of California Riverside) Work with Professor Kathleen Montgomery on institutional theory

Selected grants

2017

  • How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States; Mintzes B, Roughead E, Lexchin J, Bero L, Dormuth C, Kesselheim A, Lipworth W, De Bruin M, Gnjidic D, Puil L; National Health and Medical Research Council (NHMRC)/Project Grants.

2015

  • Regulating Autologous Stem Cell Therapies in Australia; Stewart C, Kerridge I, Waldby C, Munsie M, Lipworth W, Lysaght T; Australian Research Council (ARC)/Linkage Projects (LP).
  • Biobank Networks, Medical Research and the Challenge of Globalisation; Kerridge I, Stewart C, Cumming R, Easteal S, Kowal E, Waldby C, Lipworth W, Critchley C, Anderson W, Marlton P; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Improving decisions about the funding of high cost cancer medicines in Australia; Lipworth W, Kerridge I, Salkeld G, Olver I, Isaacs D, Pearson S; National Health and Medical Research Council (NHMRC)/Project Grants.

2014

  • Population Health CDF Level 1 - Social values, ethics and politics in health technology assessment; Lipworth W; National Health and Medical Research Council (NHMRC)/Career Development Fellowships.
  • Addressing conflicts of interest in public health and biomedicine: enhancing professional integrity and safeguarding the public’s health; Lipworth W, Kerridge I, Komesaroff P, Stewart C, Olver I; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Calling the tune Investigating corporate influences on media reporting on health; Chapman S, Kerridge I, Jordens C, Bacon W, Bonfiglioni C, Sweet M, Lipworth W; National Health and Medical Research Council (NHMRC)/Project Grants.

2005

  • An empirical study into the ethical issues affecting tumour (research) banks in New South Wales.; Kerridge I, Bokey E, Little J, Lipworth W; University of Sydney/Cancer Research Fund.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Little, J., Lipworth, W. (2007). Focused Discourse: An Exploratory Essay - VELiM Occasional Monographs Series No. 2. Australia: Centre for Values, Ethics and the Law in Medicine, University of Sydney.

Book Chapters

  • Lipworth, W. (2016). Pharmaceuticals, money and the healthcare organisational field. In E. Ferlie, K. Montgomery and A. R. Pedersen (Eds.), The Oxford Handbook of Health Care Management, (pp. 496-526). Oxford: Oxford University Press.
  • Montgomery, K., Lipworth, W., Fitzgerald, L. (2015). The Persistence of Professional Boundaries in Healthcare: A Re-examination Using a Theory of Foundational Values. In S B Waldorff, A R Pedersen, L Fitzgerald, E Ferlie (Eds.), Managing Change: From Health Policy to Practice, (pp. 73-87). Basingstoke: Palgrave Macmillan.
  • Lipworth, W., Montgomery, K. (2014). Eliciting axioms to enrich debates about the pharmaceutical industry. In Michael Loughlin (Eds.), Debates in Values-Based Practice: Arguments For and Against, (pp. 184-197). Cambridge: Cambridge University Press.
  • Stewart, C., Aparicio, L., Lipworth, W., Kerridge, I. (2014). Public Umbilical Cord Blood Banking and Charitable Trusts. In Imogen Goold, Kate Greasley, Jonathan Herring, Loane Skene (Eds.), Persons, Parts and Property: How Should we Regulate Human Tissue in the 21st Century?, (pp. 53-65). Oxford, United Kingdom: Hart Publishing.
  • Stewart, C., Lipworth, W., Aparicio, L., Fleming, J., Kerridge, I. (2014). The Problems of Biobanking and the Law of Gifts. In Imogen Goold, Kate Greasley, Jonathan Herring, Loane Skene (Eds.), Persons, Parts and Property: How Should we Regulate Human Tissue in the 21st Century?, (pp. 25-38). Oxford, United Kingdom: Hart Publishing.
  • Montgomery, K., Lipworth, W. (2014). Using the survival-security-flourishing model to explain the emergence and shape of the medical profession. In Michael Loughlin (Eds.), Debates in Values-Based Practice: Arguments For and Against, (pp. 198-208). Cambridge: Cambridge University Press.
  • Lipworth, W., Little, J., Gordon, J., Markham, P., Kerridge, I. (2013). The place of patient-centred care in medical professional culture: a qualitative study. In Mary A. Keating, Aoife M. McDermott, Kathleen Montgomery (Eds.), Patient-Centred Health Care: Achieving Co-ordination, Communication and Innovation, (pp. 53-62). Basingstoke, UK: Palgrave Macmillan.
  • Lipworth, W., Strong, K., Kerridge, I. (2012). Medical ethics. In P. Bowden (Eds.), Applied Ethics: Strengthening Ethical Practices, (pp. 107-118). Prahran, Vic: Tilde University Press.

Journals

  • Vitry, A., Mintzes, B., Lipworth, W. (2016). Access to new cancer medicines in Australia: dispelling the myths and informing a public debate. Journal of Pharmaceutical Policy and Practice, 9(3), 1-6. [More Information]
  • Ghinea, N., Lipworth, W. (2016). Affordable access to innovative cancer medicines - don't forget the prices. Medical Journal of Australia, 204(6), 214-215.e1. [More Information]
  • Basedow, M., Runciman, W., Lipworth, W., Esterman, A. (2016). Australian general practitioner attitudes to clinical practice guidelines and some implications for translating osteoarthritis care into practice. Australian Journal of Primary Health, 22(5), 403-408. [More Information]
  • Mayes, C., Kerridge, I., Habibi, R., Lipworth, W. (2016). Conflicts of interest in neoliberal times: perspectives of Australian medical students. Health Sociology Review, 25(3), 256-271. [More Information]
  • Mayes, C., Lipworth, W., Kerridge, I. (2016). Declarations, accusations and judgement: examining conflict of interest discourses as performative speech-acts. Medicine, Health Care and Philosophy, 19(3), 455-462. [More Information]
  • Mason, P., Lipworth, W., Kerridge, I. (2016). More Than One Way to Be Global: Globalization of Research and the Contest of Ideas. The American Journal of Bioethics, 16(10), 48-49. [More Information]
  • Lipworth, W., Ghinea, N., Kerridge, I. (2016). Negotiating limits to the funding of high cost cancer medicines. Cancer Forum, 40(2), 93-96.
  • Mayes, C., Blakely, B., Kerridge, I., Komesaroff, P., Olver, I., Lipworth, W. (2016). On the fragility of medical virtue in a neoliberal context: the case of commercial conflicts of interest in reproductive medicine. Theoretical Medicine and Bioethics, 37(1), 97-111. [More Information]
  • Ghinea, N., Lipworth, W., Kerridge, I. (2016). Propaganda or the cost of innovation? Challenging the high price of new drugs. BMJ, 352, 1-4. [More Information]
  • Robertson, M., Light, E., Walter, G., Lipworth, W. (2016). Psychiatry and the 'Gay Holocaust' - the lessons of Jill Soloway's Transparent. Australasian Psychiatry, 24(6), 571-574. [More Information]
  • Williams, J., Mayes, C., Lipworth, W. (2016). Students face deep conflict in reporting harassment. BMJ, 354, 1-1. [More Information]
  • Salkeld, G., Cunich, M., Dowie, J., Howard, K., Patel, M., Mann, G., Lipworth, W. (2016). The role of personalised choice in decision support: A randomized controlled trial of an online decision aid for prostate cancer screening. PloS One, 11(4), 1-17. [More Information]
  • Lipworth, W., Axler, R. (2016). Towards a bioethics of innovation. Journal of Medical Ethics, 42(7), 445-449. [More Information]
  • Wortley, S., Street, J., Lipworth, W., Howard, K. (2016). What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations? Journal of Health Organization and Management, 30(6), 872-890. [More Information]
  • Mayes, C., Lipworth, W., Kerridge, I. (2015). Clarifying the costs of conflicts of interest. International Journal of Clinical Practice, 69(3), 384-385. [More Information]
  • Lipworth, W., Kerridge, I. (2015). Consent to Biobank Research: Facing Up to the Challenge of Globalization. The American Journal of Bioethics, 15(9), 58-59. [More Information]
  • Lewis, J., Kerridge, I., Lipworth, W. (2015). Coverage With Evidence Development and Managed Entry in the Funding of Personalized Medicine: Practical and Ethical Challenges for Oncology. Journal of Clinical Oncology, 33(34), 4112-4117. [More Information]
  • Ghinea, N., Lipworth, W., Kerridge, I. (2015). Evidence, regulation and 'rational' prescribing: The case of gabapentin for neuropathic pain. Journal of Evaluation in Clinical Practice, 21(1), 28-33. [More Information]
  • Pace, J., Pearson, S., Lipworth, W. (2015). Improving the Legitimacy of Medicines Funding Decisions: A Critical Literature Review. Therapeutic Innovation and Regulatory Science, 49(3), 364-368. [More Information]
  • Ghinea, N., Lipworth, W., Kerridge, I. (2015). Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable? Therapeutic Innovation and Regulatory Science, 49(3), 359-363. [More Information]
  • Ghinea, N., Lipworth, W., Little, J., Kerridge, I., Day, R. (2015). Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage. Developing World Bioethics, 15(1), 48-54. [More Information]
  • Morrell, B., Forsyth, R., Lipworth, W., Kerridge, I., Jordens, C. (2015). Rules of engagement: Journalists' attitudes to industry influence in health news reporting. Journalism, 16(5), 596-614. [More Information]
  • Day, R., Lipworth, W., Ghinea, N. (2015). The Ethics Around Drug Labels and Generic Medicines. Therapeutic Innovation and Regulatory Science, 49(3), 348-351. [More Information]
  • Richards, B., Porter, G., Lipworth, W., Lysaght, T. (2015). The Medical Innovation Bill: Still more harm than good. Clinical Ethics, 10(1-2), 1-4. [More Information]
  • Degeling, C., Mayes, C., Lipworth, W., Kerridge, I., Upshur, R. (2015). The Political and Ethical Challenge of Multi-Drug Resistant Tuberculosis. Bioethical Inquiry, 12(1), 107-113. [More Information]
  • Lipworth, W., Kerridge, I., Morrell, B., Forsyth, R., Jordens, C. (2015). Views of health journalists, industry employees and news consumers about disclosure and regulation of industry-journalist relationships: An empirical ethical study. Journal of Medical Ethics, 41(3), 252-257. [More Information]
  • Newson, A., Lipworth, W. (2015). Why should ethics approval be required prior to publication of health promotion research? Health Promotion Journal of Australia, 26(3), 170-175. [More Information]
  • Inam, S., Lipworth, W., Kerridge, I., Day, R. (2014). A review of strategies to improve rational prescribing in asthma. Journal of Pharmacy Practice and Research, 44, 195-200. [More Information]
  • Lipworth, W., Doran, E., Kerridge, I., Day, R. (2014). Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy. Australian Health Review, 38(2), 160-168. [More Information]
  • Lipworth, W., Little, J. (2014). Deriving and Critiquing an Empirically-Based Framework for Pharmaceutical Ethics. AJOB Empirical Bioethics, 5(1), 23-32. [More Information]
  • Lewis, J., Lipworth, W., Kerridge, I., Doran, E. (2014). Dilemmas in the compassionate supply of investigational cancer drugs. Internal Medicine Journal, 44(9), 841-845. [More Information]
  • Ghinea, N., Lipworth, W., Kerridge, I., Little, J., Day, R. (2014). Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII. Hastings Center Report, 44(2).
  • Lewis, J., Lipworth, W., Kerridge, I. (2014). Ethics, Evidence and Economics in the Pursuit of "Personalized Medicine". Journal of Personalized Medicine, 4(2), 137-146. [More Information]
  • Little, M., Gordon, J., Lipworth, W., Markham, P., Kerridge, I. (2014). Values as 'modest foundations' for medicine. European Journal for Person Centered Healthcare, 2(2), 154-161. [More Information]
  • Aparicio, L., Lipworth, W., Then, S., Stewart, C., Coghlan, P., Kerridge, I., Fleming, J. (2013). Biobanking of blood and bone marrow: Emerging challenges for custodians of public resources. Journal of Law and Medicine, 21(2), 343-350. [More Information]
  • Lipworth, W., Taylor, N., Braithwaite, J. (2013). Can the theoretical domains framework account for the implementation of clinical quality interventions? BMC Health Services Research, 13(1), 1-13. [More Information]
  • Lipworth, W., Little, J., Markham, P., Gordon, J., Kerridge, I. (2013). Doctors on Status and Respect: A Qualitative Study. Bioethical Inquiry, 10(2), 205-217. [More Information]
  • Lipworth, W., Kerridge, I., Day, R. (2013). Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization. Therapeutic Innovation and Regulatory Science, 47(1), 46-49. [More Information]
  • Lipworth, W., Montgomery, K., Little, J. (2013). How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism. Bioethical Inquiry, 10(3), 355-367. [More Information]
  • Lewis, J., Lipworth, W., Kerridge, I., O Day, R. (2013). The economic evaluation of personalised oncology medicines: ethical challenges. Medical Journal of Australia, 199(7), 471-473. [More Information]
  • Jordens, C., Lipworth, W., Kerridge, I. (2013). The quality of Australian health journalism is important for public health. Medical Journal of Australia, 199(7), 448-449. [More Information]
  • Lipworth, W., Kerridge, I. (2013). Why drug shortages are an ethical issue. The Australasian Medical Journal, 6(11), 556-559. [More Information]
  • Lipworth, W., Ho, K., Kerridge, I., Day, R. (2012). Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency. Medical Journal of Australia, 197(4), 204-205. [More Information]
  • Lipworth, W., Kerridge, I., Little, J., Day, R. (2012). Evidence and desperation in off-label prescribing: recombinant factor VIIa. BMJ, 344(7840), 1-3. [More Information]
  • Forsyth, R., Morrell, B., Lipworth, W., Kerridge, I., Jordens, C., Chapman, S. (2012). Health Journalists' Perceptions of Their Professional Roles and Responsibilities for Ensuring the Veracity of Reports of Health Research. Journal of Mass Media Ethics: exploring questions of media morality, 27(2), 130-141. [More Information]
  • Lipworth, W., Kerridge, I., Little, J., Gordon, J., Markham, P. (2012). Meaning and value in medical school curricula. Journal of Evaluation in Clinical Practice, 18(5), 1027-1035. [More Information]
  • Lipworth, W., Kerridge, I., Morrell, B., Bonfiglioli, C., Forsyth, R. (2012). Medicine, the media and political interests. Journal of Medical Ethics, 38(12), 768-770. [More Information]
  • Ghinea, N., Ghinea, N., Lipworth, W., Lipworth, W., Kerridge, I., Kerridge, I., Day, R., Day, R. (2012). No evidence or no alternative? Taking responsibility for off-label prescribing. Internal Medicine Journal, 42(3), 247-251. [More Information]
  • Komesaroff, P., Kerridge, I., Stewart, C., Samuel, G., Lipworth, W., Jordens, C. (2012). Racially conditional donation: the example of umbilical cord blood. Journal of Law and Medicine, 19(3), 517-524. [More Information]
  • Gordon, J., Markham, P., Lipworth, W., Kerridge, I., Little, J. (2012). The dual nature of medical enculturation in postgraduate medical training and practice. Medical Education, 46(9), 894-902. [More Information]
  • Little, J., Lipworth, W., Gordon, J., Markham, P., Kerridge, I. (2012). Values-based medicine and modest foundationalism. Journal of Evaluation in Clinical Practice, 18(5), 1020-1026. [More Information]
  • Lipworth, W., Kerridge, I., Sweet, M., Jordens, C., Bonfiglioli, C., Forsyth, R. (2012). Widening the debate about conflict of interest: addressing relationships between journalists and the pharmaceutical industry. Journal of Medical Ethics, 38(8), 492-495. [More Information]
  • Lipworth, W., Kerridge, I., Day, R. (2012). Wrong Questions, Wrong Answers? Are We Getting the Drugs We Need? Clinical Pharmacology & Therapeutics, 91(3), 367-369. [More Information]
  • Milder, T., Lipworth, W., Williams, K., Ritchie, J., Day, R. (2011). "It looks after me": how older patients make decisions about analgesics for osteoarthritis. Arthritis Care and Research, 63(9), 1280-1286. [More Information]
  • Little, J., Lipworth, W., Gordon, J., Markham, P. (2011). Another argument for values-based medicine. The International Journal of Person Centered Medicine, 1(4), 649-656. [More Information]
  • Lipworth, W., Hooker, C., Carter, S. (2011). Balance, Balancing, and Health. Qualitative Health Research, 21(5), 714-725. [More Information]
  • Morrell, B., Lipworth, W., Axler, R., Kerridge, I., Little, J. (2011). Cancer as Rubbish: Donation of Tumor Tissue for Research. Qualitative Health Research, 21(1), 75-84. [More Information]
  • Day, R., Lipworth, W., Kerridge, I. (2011). Death of the 'Blockbuster' and 'Pivotal' clinical trial: Rethinking the drug development process. Journal of Pharmacy Practice and Research, 41(2), 94-96.
  • Wang, N., Lipworth, W., Ritchie, J., Williams, K., Day, R. (2011). Eliciting views of Australian Pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines. Internal Medicine Journal, 41(4), 314-320. [More Information]
  • Crowther, H., Lipworth, W., Kerridge, I. (2011). Evidence-based medicine and epistemological imperialism: narrowing the divide between evidence and illness. Journal of Evaluation in Clinical Practice, 17(5), 868-872. [More Information]
  • Lipworth, W., Kerridge, I., Brett, J., Day, R. (2011). How clinical and research failures lead to suboptimal prescribing: the example of chronic gout. BMJ: British Medical Journal, 343(7835), d7459-1-d7459-3. [More Information]
  • Lipworth, W., Kerridge, I., Carter, S., Little, J. (2011). Journal peer review in context: A qualitative study of the social and subjective dimensions of manuscript review in biomedical publishing. Social Science and Medicine, 72(7), 1056-1063. [More Information]
  • Little, J., Gordon, J., Markham, P., Lipworth, W., Kerridge, I. (2011). Making decisions in the mechanistic, probabilistic and scientific domains of medicine: a qualitative study of medical practitioners. The International Journal of Person Centred Medicine, 1(2), 376-384.
  • Inam, S., Lipworth, W., Kerridge, I., O Day, R. (2011). Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment. Medical Journal of Australia, 195(8), 446-447. [More Information]
  • Harvey, K., Day, R., Campbell, W., Lipworth, W. (2011). Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration? Medical Journal of Australia, 194(11), 567-568.
  • Lipworth, W., Kerridge, I. (2011). Shifting Power Relations and the Ethics of Journal Peer Review. Social Epistemology, 25(1), 97-121. [More Information]
  • Lipworth, W., Kerridge, I., Carter, S., Little, J. (2011). Should Biomedical Publishing Be 'Opened Up'? Towards a Values-Based Peer-Review Process. Bioethical Inquiry, 8(3), 267-280. [More Information]
  • Lipworth, W., Little, J., Kerridge, I. (2011). The perils of proxy outcomes in evidence-based medicine: the case of recombinant factor VIIa. The International Journal of Person Centred Medicine, 1(4), 657-659.
  • Lipworth, W., Forsyth, R., Kerridge, I. (2011). Tissue donation to biobanks: a review of sociological studies. Sociology of Health and Illness, 33(5), 792-811. [More Information]
  • Milder, T., Williams, K., Ritchie, J., Lipworth, W., Day, R. (2011). Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of risk. Age and Ageing, 40(2), 254-259. [More Information]
  • Lipworth, W., Kerridge, I. (2011). Where to now for health-related journal peer review? Journal of Law and Medicine, 18(4), 724-727. [More Information]
  • Lipworth, W., Kerridge, I. (2011). Where to now for health-related journal peer-review? Journal of Law and Medicine, 18(4), 724-727. [More Information]
  • Lipworth, W., Wodak, A., Haber, P., Day, R. (2011). Why is Disulfiram not on the PBS? Medical Journal of Australia, 195(7), 371-372. [More Information]
  • Lipworth, W., Davey, H., Carter, S., Hooker, C., Hu, W. (2010). Beliefs and beyond: what can we learn from qualitative studies of lay people's understandings of cancer risk? Health Expectations, 13(2), 113-124. [More Information]
  • Lipworth, W., Kerridge, I. (2010). Impediments to "T2" research: are ethics really to blame? The American Journal of Bioethics, 10(8), 39-40. [More Information]
  • Strong, K., Lipworth, W., Kerridge, I. (2010). The strengths and limitations of empirical bioethics. Journal of Law and Medicine, 18(2), 316-319.
  • Lipworth, W., Morrell, B., Irvine, R., Kerridge, I. (2009). An empirical reappraisal of public trust in biobanking research: rethinking restrictive consent requirements. Journal of Law and Medicine, 17(1), 119-132. [More Information]
  • Lipworth, W. (2009). Beyond the consulting room: intuition and intersubjectivity in journal peer review. Australasian Psychiatry, 17(4), 331-334. [More Information]
  • Lipworth, W., Irvine, R., Morrell, B. (2009). Consent: a need for guidelines to reflect local considerations. Nature, 461(7264), 593-593. [More Information]
  • Lipworth, W., Morrell, B., Kerridge, I. (2008). Ethics as an act of listening. The American Journal of Bioethics, 8(10), 80-81. [More Information]
  • Little, J., Jordens, C., McGrath, C., Montgomery, K., Lipworth, W., Kerridge, I. (2008). Informed consent and medical ordeal: A qualitative study. Internal Medicine Journal, 38(8), 624-628. [More Information]
  • Lipworth, W., Carter, S., Kerridge, I. (2008). The "EBM Movement": Where Did it Come From, Where is it Going, and Why Does it Matter? Social Epistemology, 22(4), 425-431. [More Information]
  • Komesaroff, P., Kerridge, I., Lipworth, W. (2008). The Epistemology and Ethics of Journal Reviewing: A Second Look. Bioethical Inquiry, 5(1), 3-6. [More Information]
  • Axler, R., Irvine, R., Lipworth, W., Morrell, B., Kerridge, I. (2008). Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research. Pathobiology: exploring the basis of disease, 75(6), 323-329. [More Information]
  • Lipworth, W. (2007). Managing scientific uncertainty in health legislation. Internal Medicine Journal, 37(2), 119-123. [More Information]
  • Clark, G., Lipworth, W., Bokey, E., Little, J., Kerridge, I. (2006). An empirical study of tissue banking in Australia: navigating regulatory and ethical challenges. Journal of Law and Medicine, 14(1), 102-109. [More Information]
  • Lipworth, W., Ankeny, R., Kerridge, I. (2006). Consent in crisis: the need to reconceptualize consent to tissue banking research. Internal Medicine Journal, 36(2), 124-128. [More Information]
  • Lipworth, W. (2005). Generating a Taxonomy of Regulatory Responses to Emerging Issues in Biomedicine. Bioethical Inquiry, 2(3), 130-141. [More Information]
  • Kerridge, I., Ankeny, R., Jordens, C., Lipworth, W. (2005). In reply (to letters on "Increasing diversity at the cost of decreasing equity? Issues raised by the establishment of Australia's first religiously affiliated medical school"). Medical Journal of Australia, 183(6), 333.
  • Kerridge, I., Ankeny, R., Jordens, C., Lipworth, W. (2005). Increasing diversity at the cost of decreasing equity? Issues raised by the establishment of Australia's first religiously affiliated medical school. Medical Journal of Australia, 183(1), 28-30. [More Information]
  • Lipworth, W. (2005). Navigating tissue banking regulation: conceptual frameworks for researchers, administrators, regulators and policy-makers. Journal of Law and Medicine, 13(2), 245-255.

Conferences

  • Lipworth, W., Little, J. (2013). A theory of values for health technology assessment. 10th Annual Conference of Health Technology Assessment International (HTAi 2013), Seoul, Korea.
  • Lipworth, W., Montgomery, K., Little, J. (2013). How Pharmaceutical Industry Employees Manage Competing Moral Commitments. 73rd Annual Meeting of the Academy of Management 2013, Orlando, United States: Academy of Management.
  • Lipworth, W., Montgomery, K. (2013). How Professional Employees of Pharmaceutical Companies Negotiate Commercial and Scientific Value Sets to Minimise Harm to Patients. Australasian Association of Bioethics & Health Law Conference 2012, Auckland, New Zealand.
  • Lipworth, W., Little, J. (2013). Towards a Principle-Based Pharmaceutical Ethics: A Modern Incarnation of Beauchamp and Childress's "Principles of Biomedical Ethics". Australasian Association of Bioethics & Health Law Conference 2013, Sydney, NSW, Australia.
  • Lipworth, W., Little, J., Kerridge, I. (2012). Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes. The New Zealand Bioethics Conference 2012: No Country for Old Men (or Women), Dunedin, New Zealand.
  • Lipworth, W., Little, J., Markham, P., Gordon, J., Kerridge, I. (2012). The place of patient-centred care in medical culture: a qualitative study. 8th International Organisation Behaviour in Healthcare Conference 2012, Dublin, Ireland.
  • Milder, T., Lipworth, W., Ritchie, J., Williams, K., Day, R. (2011). What drives osteoarthritis patients to use or not use NSAIDs, paracetamol and complimentary medicine? 52nd Annual Scientific Meeting of the Australian Rheumatology Association 2011, Brisbane, Queensland, Australia.
  • Lipworth, W. (2010). Power and vulnerability in journal peer review. 2010 Australasian Association for the History, Philosophy and Social Studies of Science Conference (A2HPS3), Sydney, NSW, Australia.
  • Lipworth, W., Montgomery, K. (2010). The Journal Peer Review Process: Revealing a Layered Institutional Logic. 2010 Academy of Management Annual Meeting, United States: Academy of Management.
  • Lipworth, W. (2009). EBM: Shifting the Debate. Joint Sydney-Tilburg Conference on "Evidence, Science and Public Policy", Sydney, NSW, Australia.
  • Lipworth, W. (2009). Journal peer review as a moral enterprise. Australasian Association of Bioethics & Health Law Conference 2009, Queenstown, New Zealand.
  • Lipworth, W. (2009). Subjectivity and the Science of Peer Review. 6th International Congress on Peer Review and Biomedical Publication 2009, Vancouver, British Columbia, Canada.

2016

  • Vitry, A., Mintzes, B., Lipworth, W. (2016). Access to new cancer medicines in Australia: dispelling the myths and informing a public debate. Journal of Pharmaceutical Policy and Practice, 9(3), 1-6. [More Information]
  • Ghinea, N., Lipworth, W. (2016). Affordable access to innovative cancer medicines - don't forget the prices. Medical Journal of Australia, 204(6), 214-215.e1. [More Information]
  • Basedow, M., Runciman, W., Lipworth, W., Esterman, A. (2016). Australian general practitioner attitudes to clinical practice guidelines and some implications for translating osteoarthritis care into practice. Australian Journal of Primary Health, 22(5), 403-408. [More Information]
  • Mayes, C., Kerridge, I., Habibi, R., Lipworth, W. (2016). Conflicts of interest in neoliberal times: perspectives of Australian medical students. Health Sociology Review, 25(3), 256-271. [More Information]
  • Mayes, C., Lipworth, W., Kerridge, I. (2016). Declarations, accusations and judgement: examining conflict of interest discourses as performative speech-acts. Medicine, Health Care and Philosophy, 19(3), 455-462. [More Information]
  • Mason, P., Lipworth, W., Kerridge, I. (2016). More Than One Way to Be Global: Globalization of Research and the Contest of Ideas. The American Journal of Bioethics, 16(10), 48-49. [More Information]
  • Lipworth, W., Ghinea, N., Kerridge, I. (2016). Negotiating limits to the funding of high cost cancer medicines. Cancer Forum, 40(2), 93-96.
  • Mayes, C., Blakely, B., Kerridge, I., Komesaroff, P., Olver, I., Lipworth, W. (2016). On the fragility of medical virtue in a neoliberal context: the case of commercial conflicts of interest in reproductive medicine. Theoretical Medicine and Bioethics, 37(1), 97-111. [More Information]
  • Lipworth, W. (2016). Pharmaceuticals, money and the healthcare organisational field. In E. Ferlie, K. Montgomery and A. R. Pedersen (Eds.), The Oxford Handbook of Health Care Management, (pp. 496-526). Oxford: Oxford University Press.
  • Ghinea, N., Lipworth, W., Kerridge, I. (2016). Propaganda or the cost of innovation? Challenging the high price of new drugs. BMJ, 352, 1-4. [More Information]
  • Robertson, M., Light, E., Walter, G., Lipworth, W. (2016). Psychiatry and the 'Gay Holocaust' - the lessons of Jill Soloway's Transparent. Australasian Psychiatry, 24(6), 571-574. [More Information]
  • Williams, J., Mayes, C., Lipworth, W. (2016). Students face deep conflict in reporting harassment. BMJ, 354, 1-1. [More Information]
  • Salkeld, G., Cunich, M., Dowie, J., Howard, K., Patel, M., Mann, G., Lipworth, W. (2016). The role of personalised choice in decision support: A randomized controlled trial of an online decision aid for prostate cancer screening. PloS One, 11(4), 1-17. [More Information]
  • Lipworth, W., Axler, R. (2016). Towards a bioethics of innovation. Journal of Medical Ethics, 42(7), 445-449. [More Information]
  • Wortley, S., Street, J., Lipworth, W., Howard, K. (2016). What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations? Journal of Health Organization and Management, 30(6), 872-890. [More Information]

2015

  • Mayes, C., Lipworth, W., Kerridge, I. (2015). Clarifying the costs of conflicts of interest. International Journal of Clinical Practice, 69(3), 384-385. [More Information]
  • Lipworth, W., Kerridge, I. (2015). Consent to Biobank Research: Facing Up to the Challenge of Globalization. The American Journal of Bioethics, 15(9), 58-59. [More Information]
  • Lewis, J., Kerridge, I., Lipworth, W. (2015). Coverage With Evidence Development and Managed Entry in the Funding of Personalized Medicine: Practical and Ethical Challenges for Oncology. Journal of Clinical Oncology, 33(34), 4112-4117. [More Information]
  • Ghinea, N., Lipworth, W., Kerridge, I. (2015). Evidence, regulation and 'rational' prescribing: The case of gabapentin for neuropathic pain. Journal of Evaluation in Clinical Practice, 21(1), 28-33. [More Information]
  • Pace, J., Pearson, S., Lipworth, W. (2015). Improving the Legitimacy of Medicines Funding Decisions: A Critical Literature Review. Therapeutic Innovation and Regulatory Science, 49(3), 364-368. [More Information]
  • Ghinea, N., Lipworth, W., Kerridge, I. (2015). Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable? Therapeutic Innovation and Regulatory Science, 49(3), 359-363. [More Information]
  • Ghinea, N., Lipworth, W., Little, J., Kerridge, I., Day, R. (2015). Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage. Developing World Bioethics, 15(1), 48-54. [More Information]
  • Morrell, B., Forsyth, R., Lipworth, W., Kerridge, I., Jordens, C. (2015). Rules of engagement: Journalists' attitudes to industry influence in health news reporting. Journalism, 16(5), 596-614. [More Information]
  • Day, R., Lipworth, W., Ghinea, N. (2015). The Ethics Around Drug Labels and Generic Medicines. Therapeutic Innovation and Regulatory Science, 49(3), 348-351. [More Information]
  • Richards, B., Porter, G., Lipworth, W., Lysaght, T. (2015). The Medical Innovation Bill: Still more harm than good. Clinical Ethics, 10(1-2), 1-4. [More Information]
  • Montgomery, K., Lipworth, W., Fitzgerald, L. (2015). The Persistence of Professional Boundaries in Healthcare: A Re-examination Using a Theory of Foundational Values. In S B Waldorff, A R Pedersen, L Fitzgerald, E Ferlie (Eds.), Managing Change: From Health Policy to Practice, (pp. 73-87). Basingstoke: Palgrave Macmillan.
  • Degeling, C., Mayes, C., Lipworth, W., Kerridge, I., Upshur, R. (2015). The Political and Ethical Challenge of Multi-Drug Resistant Tuberculosis. Bioethical Inquiry, 12(1), 107-113. [More Information]
  • Lipworth, W., Kerridge, I., Morrell, B., Forsyth, R., Jordens, C. (2015). Views of health journalists, industry employees and news consumers about disclosure and regulation of industry-journalist relationships: An empirical ethical study. Journal of Medical Ethics, 41(3), 252-257. [More Information]
  • Newson, A., Lipworth, W. (2015). Why should ethics approval be required prior to publication of health promotion research? Health Promotion Journal of Australia, 26(3), 170-175. [More Information]

2014

  • Inam, S., Lipworth, W., Kerridge, I., Day, R. (2014). A review of strategies to improve rational prescribing in asthma. Journal of Pharmacy Practice and Research, 44, 195-200. [More Information]
  • Lipworth, W., Doran, E., Kerridge, I., Day, R. (2014). Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy. Australian Health Review, 38(2), 160-168. [More Information]
  • Lipworth, W., Little, J. (2014). Deriving and Critiquing an Empirically-Based Framework for Pharmaceutical Ethics. AJOB Empirical Bioethics, 5(1), 23-32. [More Information]
  • Lewis, J., Lipworth, W., Kerridge, I., Doran, E. (2014). Dilemmas in the compassionate supply of investigational cancer drugs. Internal Medicine Journal, 44(9), 841-845. [More Information]
  • Lipworth, W., Montgomery, K. (2014). Eliciting axioms to enrich debates about the pharmaceutical industry. In Michael Loughlin (Eds.), Debates in Values-Based Practice: Arguments For and Against, (pp. 184-197). Cambridge: Cambridge University Press.
  • Ghinea, N., Lipworth, W., Kerridge, I., Little, J., Day, R. (2014). Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII. Hastings Center Report, 44(2).
  • Lewis, J., Lipworth, W., Kerridge, I. (2014). Ethics, Evidence and Economics in the Pursuit of "Personalized Medicine". Journal of Personalized Medicine, 4(2), 137-146. [More Information]
  • Stewart, C., Aparicio, L., Lipworth, W., Kerridge, I. (2014). Public Umbilical Cord Blood Banking and Charitable Trusts. In Imogen Goold, Kate Greasley, Jonathan Herring, Loane Skene (Eds.), Persons, Parts and Property: How Should we Regulate Human Tissue in the 21st Century?, (pp. 53-65). Oxford, United Kingdom: Hart Publishing.
  • Stewart, C., Lipworth, W., Aparicio, L., Fleming, J., Kerridge, I. (2014). The Problems of Biobanking and the Law of Gifts. In Imogen Goold, Kate Greasley, Jonathan Herring, Loane Skene (Eds.), Persons, Parts and Property: How Should we Regulate Human Tissue in the 21st Century?, (pp. 25-38). Oxford, United Kingdom: Hart Publishing.
  • Montgomery, K., Lipworth, W. (2014). Using the survival-security-flourishing model to explain the emergence and shape of the medical profession. In Michael Loughlin (Eds.), Debates in Values-Based Practice: Arguments For and Against, (pp. 198-208). Cambridge: Cambridge University Press.
  • Little, M., Gordon, J., Lipworth, W., Markham, P., Kerridge, I. (2014). Values as 'modest foundations' for medicine. European Journal for Person Centered Healthcare, 2(2), 154-161. [More Information]

2013

  • Lipworth, W., Little, J. (2013). A theory of values for health technology assessment. 10th Annual Conference of Health Technology Assessment International (HTAi 2013), Seoul, Korea.
  • Aparicio, L., Lipworth, W., Then, S., Stewart, C., Coghlan, P., Kerridge, I., Fleming, J. (2013). Biobanking of blood and bone marrow: Emerging challenges for custodians of public resources. Journal of Law and Medicine, 21(2), 343-350. [More Information]
  • Lipworth, W., Taylor, N., Braithwaite, J. (2013). Can the theoretical domains framework account for the implementation of clinical quality interventions? BMC Health Services Research, 13(1), 1-13. [More Information]
  • Lipworth, W., Little, J., Markham, P., Gordon, J., Kerridge, I. (2013). Doctors on Status and Respect: A Qualitative Study. Bioethical Inquiry, 10(2), 205-217. [More Information]
  • Lipworth, W., Kerridge, I., Day, R. (2013). Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization. Therapeutic Innovation and Regulatory Science, 47(1), 46-49. [More Information]
  • Lipworth, W., Montgomery, K., Little, J. (2013). How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism. Bioethical Inquiry, 10(3), 355-367. [More Information]
  • Lipworth, W., Montgomery, K., Little, J. (2013). How Pharmaceutical Industry Employees Manage Competing Moral Commitments. 73rd Annual Meeting of the Academy of Management 2013, Orlando, United States: Academy of Management.
  • Lipworth, W., Montgomery, K. (2013). How Professional Employees of Pharmaceutical Companies Negotiate Commercial and Scientific Value Sets to Minimise Harm to Patients. Australasian Association of Bioethics & Health Law Conference 2012, Auckland, New Zealand.
  • Lewis, J., Lipworth, W., Kerridge, I., O Day, R. (2013). The economic evaluation of personalised oncology medicines: ethical challenges. Medical Journal of Australia, 199(7), 471-473. [More Information]
  • Lipworth, W., Little, J., Gordon, J., Markham, P., Kerridge, I. (2013). The place of patient-centred care in medical professional culture: a qualitative study. In Mary A. Keating, Aoife M. McDermott, Kathleen Montgomery (Eds.), Patient-Centred Health Care: Achieving Co-ordination, Communication and Innovation, (pp. 53-62). Basingstoke, UK: Palgrave Macmillan.
  • Jordens, C., Lipworth, W., Kerridge, I. (2013). The quality of Australian health journalism is important for public health. Medical Journal of Australia, 199(7), 448-449. [More Information]
  • Lipworth, W., Little, J. (2013). Towards a Principle-Based Pharmaceutical Ethics: A Modern Incarnation of Beauchamp and Childress's "Principles of Biomedical Ethics". Australasian Association of Bioethics & Health Law Conference 2013, Sydney, NSW, Australia.
  • Lipworth, W., Kerridge, I. (2013). Why drug shortages are an ethical issue. The Australasian Medical Journal, 6(11), 556-559. [More Information]

2012

  • Lipworth, W., Ho, K., Kerridge, I., Day, R. (2012). Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency. Medical Journal of Australia, 197(4), 204-205. [More Information]
  • Lipworth, W., Kerridge, I., Little, J., Day, R. (2012). Evidence and desperation in off-label prescribing: recombinant factor VIIa. BMJ, 344(7840), 1-3. [More Information]
  • Lipworth, W., Little, J., Kerridge, I. (2012). Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes. The New Zealand Bioethics Conference 2012: No Country for Old Men (or Women), Dunedin, New Zealand.
  • Forsyth, R., Morrell, B., Lipworth, W., Kerridge, I., Jordens, C., Chapman, S. (2012). Health Journalists' Perceptions of Their Professional Roles and Responsibilities for Ensuring the Veracity of Reports of Health Research. Journal of Mass Media Ethics: exploring questions of media morality, 27(2), 130-141. [More Information]
  • Lipworth, W., Kerridge, I., Little, J., Gordon, J., Markham, P. (2012). Meaning and value in medical school curricula. Journal of Evaluation in Clinical Practice, 18(5), 1027-1035. [More Information]
  • Lipworth, W., Strong, K., Kerridge, I. (2012). Medical ethics. In P. Bowden (Eds.), Applied Ethics: Strengthening Ethical Practices, (pp. 107-118). Prahran, Vic: Tilde University Press.
  • Lipworth, W., Kerridge, I., Morrell, B., Bonfiglioli, C., Forsyth, R. (2012). Medicine, the media and political interests. Journal of Medical Ethics, 38(12), 768-770. [More Information]
  • Ghinea, N., Ghinea, N., Lipworth, W., Lipworth, W., Kerridge, I., Kerridge, I., Day, R., Day, R. (2012). No evidence or no alternative? Taking responsibility for off-label prescribing. Internal Medicine Journal, 42(3), 247-251. [More Information]
  • Komesaroff, P., Kerridge, I., Stewart, C., Samuel, G., Lipworth, W., Jordens, C. (2012). Racially conditional donation: the example of umbilical cord blood. Journal of Law and Medicine, 19(3), 517-524. [More Information]
  • Gordon, J., Markham, P., Lipworth, W., Kerridge, I., Little, J. (2012). The dual nature of medical enculturation in postgraduate medical training and practice. Medical Education, 46(9), 894-902. [More Information]
  • Lipworth, W., Little, J., Markham, P., Gordon, J., Kerridge, I. (2012). The place of patient-centred care in medical culture: a qualitative study. 8th International Organisation Behaviour in Healthcare Conference 2012, Dublin, Ireland.
  • Little, J., Lipworth, W., Gordon, J., Markham, P., Kerridge, I. (2012). Values-based medicine and modest foundationalism. Journal of Evaluation in Clinical Practice, 18(5), 1020-1026. [More Information]
  • Lipworth, W., Kerridge, I., Sweet, M., Jordens, C., Bonfiglioli, C., Forsyth, R. (2012). Widening the debate about conflict of interest: addressing relationships between journalists and the pharmaceutical industry. Journal of Medical Ethics, 38(8), 492-495. [More Information]
  • Lipworth, W., Kerridge, I., Day, R. (2012). Wrong Questions, Wrong Answers? Are We Getting the Drugs We Need? Clinical Pharmacology & Therapeutics, 91(3), 367-369. [More Information]

2011

  • Milder, T., Lipworth, W., Williams, K., Ritchie, J., Day, R. (2011). "It looks after me": how older patients make decisions about analgesics for osteoarthritis. Arthritis Care and Research, 63(9), 1280-1286. [More Information]
  • Little, J., Lipworth, W., Gordon, J., Markham, P. (2011). Another argument for values-based medicine. The International Journal of Person Centered Medicine, 1(4), 649-656. [More Information]
  • Lipworth, W., Hooker, C., Carter, S. (2011). Balance, Balancing, and Health. Qualitative Health Research, 21(5), 714-725. [More Information]
  • Morrell, B., Lipworth, W., Axler, R., Kerridge, I., Little, J. (2011). Cancer as Rubbish: Donation of Tumor Tissue for Research. Qualitative Health Research, 21(1), 75-84. [More Information]
  • Day, R., Lipworth, W., Kerridge, I. (2011). Death of the 'Blockbuster' and 'Pivotal' clinical trial: Rethinking the drug development process. Journal of Pharmacy Practice and Research, 41(2), 94-96.
  • Wang, N., Lipworth, W., Ritchie, J., Williams, K., Day, R. (2011). Eliciting views of Australian Pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines. Internal Medicine Journal, 41(4), 314-320. [More Information]
  • Crowther, H., Lipworth, W., Kerridge, I. (2011). Evidence-based medicine and epistemological imperialism: narrowing the divide between evidence and illness. Journal of Evaluation in Clinical Practice, 17(5), 868-872. [More Information]
  • Lipworth, W., Kerridge, I., Brett, J., Day, R. (2011). How clinical and research failures lead to suboptimal prescribing: the example of chronic gout. BMJ: British Medical Journal, 343(7835), d7459-1-d7459-3. [More Information]
  • Lipworth, W., Kerridge, I., Carter, S., Little, J. (2011). Journal peer review in context: A qualitative study of the social and subjective dimensions of manuscript review in biomedical publishing. Social Science and Medicine, 72(7), 1056-1063. [More Information]
  • Little, J., Gordon, J., Markham, P., Lipworth, W., Kerridge, I. (2011). Making decisions in the mechanistic, probabilistic and scientific domains of medicine: a qualitative study of medical practitioners. The International Journal of Person Centred Medicine, 1(2), 376-384.
  • Inam, S., Lipworth, W., Kerridge, I., O Day, R. (2011). Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment. Medical Journal of Australia, 195(8), 446-447. [More Information]
  • Harvey, K., Day, R., Campbell, W., Lipworth, W. (2011). Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration? Medical Journal of Australia, 194(11), 567-568.
  • Lipworth, W., Kerridge, I. (2011). Shifting Power Relations and the Ethics of Journal Peer Review. Social Epistemology, 25(1), 97-121. [More Information]
  • Lipworth, W., Kerridge, I., Carter, S., Little, J. (2011). Should Biomedical Publishing Be 'Opened Up'? Towards a Values-Based Peer-Review Process. Bioethical Inquiry, 8(3), 267-280. [More Information]
  • Lipworth, W., Little, J., Kerridge, I. (2011). The perils of proxy outcomes in evidence-based medicine: the case of recombinant factor VIIa. The International Journal of Person Centred Medicine, 1(4), 657-659.
  • Lipworth, W., Forsyth, R., Kerridge, I. (2011). Tissue donation to biobanks: a review of sociological studies. Sociology of Health and Illness, 33(5), 792-811. [More Information]
  • Milder, T., Williams, K., Ritchie, J., Lipworth, W., Day, R. (2011). Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of risk. Age and Ageing, 40(2), 254-259. [More Information]
  • Milder, T., Lipworth, W., Ritchie, J., Williams, K., Day, R. (2011). What drives osteoarthritis patients to use or not use NSAIDs, paracetamol and complimentary medicine? 52nd Annual Scientific Meeting of the Australian Rheumatology Association 2011, Brisbane, Queensland, Australia.
  • Lipworth, W., Kerridge, I. (2011). Where to now for health-related journal peer review? Journal of Law and Medicine, 18(4), 724-727. [More Information]
  • Lipworth, W., Kerridge, I. (2011). Where to now for health-related journal peer-review? Journal of Law and Medicine, 18(4), 724-727. [More Information]
  • Lipworth, W., Wodak, A., Haber, P., Day, R. (2011). Why is Disulfiram not on the PBS? Medical Journal of Australia, 195(7), 371-372. [More Information]

2010

  • Lipworth, W., Davey, H., Carter, S., Hooker, C., Hu, W. (2010). Beliefs and beyond: what can we learn from qualitative studies of lay people's understandings of cancer risk? Health Expectations, 13(2), 113-124. [More Information]
  • Lipworth, W., Kerridge, I. (2010). Impediments to "T2" research: are ethics really to blame? The American Journal of Bioethics, 10(8), 39-40. [More Information]
  • Lipworth, W. (2010). Power and vulnerability in journal peer review. 2010 Australasian Association for the History, Philosophy and Social Studies of Science Conference (A2HPS3), Sydney, NSW, Australia.
  • Lipworth, W., Montgomery, K. (2010). The Journal Peer Review Process: Revealing a Layered Institutional Logic. 2010 Academy of Management Annual Meeting, United States: Academy of Management.
  • Strong, K., Lipworth, W., Kerridge, I. (2010). The strengths and limitations of empirical bioethics. Journal of Law and Medicine, 18(2), 316-319.

2009

  • Lipworth, W., Morrell, B., Irvine, R., Kerridge, I. (2009). An empirical reappraisal of public trust in biobanking research: rethinking restrictive consent requirements. Journal of Law and Medicine, 17(1), 119-132. [More Information]
  • Lipworth, W. (2009). Beyond the consulting room: intuition and intersubjectivity in journal peer review. Australasian Psychiatry, 17(4), 331-334. [More Information]
  • Lipworth, W., Irvine, R., Morrell, B. (2009). Consent: a need for guidelines to reflect local considerations. Nature, 461(7264), 593-593. [More Information]
  • Lipworth, W. (2009). EBM: Shifting the Debate. Joint Sydney-Tilburg Conference on "Evidence, Science and Public Policy", Sydney, NSW, Australia.
  • Lipworth, W. (2009). Journal peer review as a moral enterprise. Australasian Association of Bioethics & Health Law Conference 2009, Queenstown, New Zealand.
  • Lipworth, W. (2009). Subjectivity and the Science of Peer Review. 6th International Congress on Peer Review and Biomedical Publication 2009, Vancouver, British Columbia, Canada.

2008

  • Lipworth, W., Morrell, B., Kerridge, I. (2008). Ethics as an act of listening. The American Journal of Bioethics, 8(10), 80-81. [More Information]
  • Little, J., Jordens, C., McGrath, C., Montgomery, K., Lipworth, W., Kerridge, I. (2008). Informed consent and medical ordeal: A qualitative study. Internal Medicine Journal, 38(8), 624-628. [More Information]
  • Lipworth, W., Carter, S., Kerridge, I. (2008). The "EBM Movement": Where Did it Come From, Where is it Going, and Why Does it Matter? Social Epistemology, 22(4), 425-431. [More Information]
  • Komesaroff, P., Kerridge, I., Lipworth, W. (2008). The Epistemology and Ethics of Journal Reviewing: A Second Look. Bioethical Inquiry, 5(1), 3-6. [More Information]
  • Axler, R., Irvine, R., Lipworth, W., Morrell, B., Kerridge, I. (2008). Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research. Pathobiology: exploring the basis of disease, 75(6), 323-329. [More Information]

2007

  • Little, J., Lipworth, W. (2007). Focused Discourse: An Exploratory Essay - VELiM Occasional Monographs Series No. 2. Australia: Centre for Values, Ethics and the Law in Medicine, University of Sydney.
  • Lipworth, W. (2007). Managing scientific uncertainty in health legislation. Internal Medicine Journal, 37(2), 119-123. [More Information]

2006

  • Clark, G., Lipworth, W., Bokey, E., Little, J., Kerridge, I. (2006). An empirical study of tissue banking in Australia: navigating regulatory and ethical challenges. Journal of Law and Medicine, 14(1), 102-109. [More Information]
  • Lipworth, W., Ankeny, R., Kerridge, I. (2006). Consent in crisis: the need to reconceptualize consent to tissue banking research. Internal Medicine Journal, 36(2), 124-128. [More Information]

2005

  • Lipworth, W. (2005). Generating a Taxonomy of Regulatory Responses to Emerging Issues in Biomedicine. Bioethical Inquiry, 2(3), 130-141. [More Information]
  • Kerridge, I., Ankeny, R., Jordens, C., Lipworth, W. (2005). In reply (to letters on "Increasing diversity at the cost of decreasing equity? Issues raised by the establishment of Australia's first religiously affiliated medical school"). Medical Journal of Australia, 183(6), 333.
  • Kerridge, I., Ankeny, R., Jordens, C., Lipworth, W. (2005). Increasing diversity at the cost of decreasing equity? Issues raised by the establishment of Australia's first religiously affiliated medical school. Medical Journal of Australia, 183(1), 28-30. [More Information]
  • Lipworth, W. (2005). Navigating tissue banking regulation: conceptual frameworks for researchers, administrators, regulators and policy-makers. Journal of Law and Medicine, 13(2), 245-255.

To update your profile click here. For support on your academic profile contact .